首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease.
【24h】

Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease.

机译:混合性结缔组织病患者的血管生成和血管抑制介质失衡。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: Vascular disease is common in mixed connective tissue disease (MCTD). The aim of the present study was to investigate, whether dysbalance of angiogenic and angiostatic factors occurs in MCTD. METHODS: In all, 38 patients with MCTD, and 40 patients with systemic sclerosis (SSc) for comparison, were included. Four centres contributed to this cross-sectional analysis. A total of 66 healthy volunteers were used as controls. The serum levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and endostatin were determined by ELISA. For comparisons between controls and patients with MCTD and detection of associations of serum levels with dichotomous clinical parameters in patients with MCTD the Mann-Whitney test was used. RESULTS: Serum levels of the angiogenic factor VEGF were significantly elevated in patients with MCTD and SSc. Significantly increased levels of the angiostatic factor endostatin were also detected in MCTD, but not in SSc. No differences were observed for bFGF. Levels of VEGF were higher in patients with MCTD with pulmonary arterial hypertension (PAH), acrosclerosis and myositis. In multivariate linear regression analysis, an additive model of PAH, myositis and lymphadenopathy accounted for 79% of the variability of the VEGF levels (r=0.889). CONCLUSIONS: Molecular factors modulating angiogenic responses are dysregulated in patients with MCTD and SSc with increases of VEGF in MCTD and SSc and selective upregulation of endostatin in MCTD. Furthermore, high serum levels of VEGF might characterise patients with MCTD with a more severe course of the disease with increased prevalence of PAH and myositis.
机译:目的:血管疾病在混合性结缔组织病(MCTD)中很常见。本研究的目的是调查在MCTD中是否发生血管生成和血管抑制因子的失衡。方法:总共纳入38例MCTD患者和40例系统性硬化症(SSc)患者进行比较。四个中心为这一横截面分析做出了贡献。总共66名健康志愿者被用作对照。通过ELISA测定血清中的血管内皮生长因子(VEGF),碱性成纤维细胞生长因子(bFGF)和内皮抑素的水平。为了比较对照组和患有MCTD的患者,以及检测MCTD患者的血清水平与二分临床参数之间的关系,使用了Mann-Whitney检验。结果:MCTD和SSc患者的血管生成因子VEGF水平显着升高。在MCTD中也检测到血管抑制因子内皮抑素水平显着升高,但在SSc中未检测到。没有观察到bFGF的差异。 MCTD合并肺动脉高压(PAH),肢端硬化和肌炎的患者的VEGF水平更高。在多变量线性回归分析中,PAH,肌炎和淋巴结病的附加模型占VEGF水平变异性的79%(r = 0.889)。结论:MCTD和SSc患者中调节血管生成反应的分子因子失调,MCTD和SSc中VEGF增加,MCTD中内皮抑素选择性上调。此外,高血清VEGF水平可能是MCTD患者病情较重,PAH和肌炎患病率升高的特征。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号